Telix Pharmaceuticals | TLX - Net Income

Stock Price
12.41
Daily Change
0.02 0.16%
Monthly
18.98%
Yearly
-55.36%
Q1 Forecast
11.05

Telix Pharmaceuticals reported AUD-4.83M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Cochlear AUD 161.5M 69.6M Dec/2025
CSL USD 401M 96.5M Dec/2025
Integral Diagnostics AUD 6.06M 72.81M Jun/2024
Mayne Pharma AUD -103.68M 68.4M Jun/2024
Medical Developments International AUD -226K 121K Dec/2025
Mesoblast USD -40.16M 14.05M Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Pacific Edge NZD -19.12M 3.68M Dec/2025
Paradigm Biopharmaceuticals AUD -6.42M 495.95K Jun/2025
Polynovo AUD 1.28M 1.41M Jun/2024
PYC Therapeutics AUD -22.83M 10.46M Dec/2025
Ramsay Health Care AUD 152.7M 32.4M Dec/2025
ResMed USD 392.59M 44.05M Dec/2025
Sonic Healthcare AUD 236.68M 82.29M Dec/2024